In a 2009 study ofbreast cancer, total ceramide synthase levels were increased in malignant tissue, and CerS4 was one of three ceramide synthases to show an increase inmRNA levels. A significant correlation was found between CerS4 andCerS2/CerS6 expression.[3][4] UnlikeCerS1 andCerS5, CerS4 does not sensitize cells to chemotherapeutic drugs.[5]
CerS4 may also be involved in the control ofbody weight andfood intake. Upon administration ofleptin, a decrease in ceramide levels was observed inratwhite adipose tissue, as were expression levels of a number of genes in thesphingolipid metabolic pathway, including CerS2 and CerS4.[6]
^Erez-Roman R, Pienik R, Futerman AH (2010). "Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression".Biochemical and Biophysical Research Communications.391 (1):219–223.Bibcode:2010BBRC..391..219E.doi:10.1016/j.bbrc.2009.11.035.PMID19912991.